MedTrace Logo

COVID-19 Infection

NCT05926076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 610

Last updated 2023-07-03

No results posted yet for this study

Summary

Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.

Conditions

Interventions

OTHER

Treatment plan

Patients with different diagnoses will get different treatment options

Sponsors & Collaborators

  • Shenzhen Third People's Hospital

    collaborator OTHER

  • Tianjin First Central Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2023-07-30
Completion
2023-07-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926076 on ClinicalTrials.gov